Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from cyclosporine to tacrolimus with randomized C0 versus Bayesian C4 monitoring in stable liver transplant recipients
NL-OMON31971Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of tacrolimus and cyclosporine in liver transplant (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Change in renal function. Started Aug 2009; status: active, not recruiting.
02
Drugs
tacrolimuscyclosporine
03
Conditions
liver transplant
Beyond the preview
Go deeper on NL-OMON31971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31971.